TCL Archive Drug Shortage A Boon For Levoleucovorin; Price Is 60 Times Higher Than Leucovorin January 16, 2009
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013